Lv1
60 积分 2024-11-07 加入
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group
1天前
已完结
Novel Sulfonylurea-Based NLRP3 Inflammasome Inhibitor for Efficient Treatment of Nonalcoholic Steatohepatitis, Endotoxic Shock, and Colitis
1天前
已完结
BCKDK, A Novel Hypoxia-Responsive Kinase That Exacerbates Cerebral Ischemia Injury
19天前
已完结
Cardiac intermediary metabolism in heart failure: substrate use, signalling roles and therapeutic targets
24天前
已完结
Discovery of First Branched-Chain Ketoacid Dehydrogenase Kinase (BDK) Inhibitor Clinical Candidate PF-07328948
1个月前
已完结
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
1个月前
已完结
Heart failure with preserved ejection fraction epidemiology, pathophysiology, diagnosis and treatment strategies
1个月前
已完结
RT-A1: A Novel Unimolecular Dual Natriuretic Peptide Receptor Activator For The Treatment Of Heart Failure
1个月前
已完结
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
1个月前
已完结
Discovery of a novel cardiac myosin inhibitor for the treatment of hypertrophic cardiomyopathy
1个月前
已完结
皖公网安备34019202002308
